TERT-IN-1
CAS No. 257891-65-9
TERT-IN-1( —— )
Catalog No. M37513 CAS No. 257891-65-9
TERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 248 | Get Quote |
|
| 5MG | 376 | Get Quote |
|
| 10MG | 550 | Get Quote |
|
| 25MG | 820 | Get Quote |
|
| 50MG | 1122 | Get Quote |
|
| 100MG | 1485 | Get Quote |
|
| 200MG | 2007 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTERT-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
-
DescriptionTERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number257891-65-9
-
Formula Weight321.87
-
Molecular FormulaC16H20ClN3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C1NC2=CC=C(Cl)C3=C2N1CC(N(CC=C(C)C)C3)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
YIR-821
YIR-821 is a small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 2.8 uM against YTA48P virus with no significant cytotoxicity (CC50>200 uM).
-
HIV p17 Gag 77-85
HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by intracellularly expressing a cDNA encoding an Ab to p17.
-
Abacavir
A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.
Cart
sales@molnova.com